fluphenazine enanthate has been researched along with fluphenazine in 27 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 20 (74.07) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (7.41) | 29.6817 |
2010's | 4 (14.81) | 24.3611 |
2020's | 1 (3.70) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Goude, F; Lanza, JP; Lanza, M | 1 |
Domino, EF | 1 |
Assael, M; Guy, N; Raps, A | 1 |
Walton, R | 1 |
Rampertaap, MP | 2 |
Altamura, AC; Curry, SH; Montgomery, S; Wiles, DH | 1 |
Chouinard, G; Cohen, BM; Jones, B; Sommer, BR; Waternaux, C | 1 |
Annable, L; Chouinard, G; Ross-Chouinard, A | 1 |
Awad, AG; Hogan, TP | 1 |
Glazer, WM | 1 |
Kane, JM | 1 |
Domino, EF; Kovacic, B | 2 |
Bury, RG; Donaldson, GL | 1 |
Furukawa, T; Yamada, K | 1 |
POLLACK, SL; TOURLENTES, TT; ZOCCHI, AF | 1 |
BROOKS, GW; RAVARIS, CL; WEAVER, LA | 1 |
EBERT, AG; HESS, SM | 1 |
BARSA, JA; SAUNDERS, JC | 1 |
Braga, AL; Calixto, JB; Fachinetto, R; Ferreira, J; Paixão, MW; Pereira, RP; Puntel, RL; Rocha, JB; Villarinho, JG; Wagner, C | 1 |
Citrome, L; Jaffe, A; Levine, J | 1 |
Den, R; Mimura, M; Sakurai, H; Suzuki, T; Tsutsumi, C; Uchida, H; Uchida, T | 1 |
Athayde, ML; Boligon, AA; Busanello, A; Fachinetto, R; Leal, CQ; Reckziegel, P; Reis, EM; Röpke, J; Wagner, C | 1 |
Adams, CE; Asher, R; David, A; Eisenbruch, M; Jayaswal, A; Maayan, N; Quraishi, SN; Rathbone, J | 1 |
Imai, T; Nakada, Y; Ohura, K | 1 |
4 review(s) available for fluphenazine enanthate and fluphenazine
Article | Year |
---|---|
Neuroleptic malignant syndrome.
Topics: Adolescent; Adult; Benztropine; Bromocriptine; Catatonia; Child; Child, Preschool; Diagnosis, Differential; Female; Fluphenazine; Haloperidol; Heat Exhaustion; Humans; Male; Malignant Hyperthermia; Middle Aged; Neuroleptic Malignant Syndrome; Psychotic Disorders; Schizophrenia, Paranoid; Time Factors | 1986 |
Depot fluphenazine: risk/benefit ratio.
Topics: Administration, Oral; Basal Ganglia Diseases; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Female; Fluphenazine; Humans; Injections, Intramuscular; Male; Patient Compliance; Psychotic Disorders; Receptors, Dopamine; Research Design; Risk; Schizophrenia; Schizophrenic Psychology | 1984 |
The use of depot neuroleptics: clinical experience in the United States.
Topics: Administration, Oral; Adult; Clinical Trials as Topic; Depressive Disorder; Drug Administration Schedule; Female; Fluphenazine; Humans; Male; Patient Readmission; Placebos; Psychotic Disorders; Recurrence; Schizophrenia; Schizophrenic Psychology; United States | 1984 |
Fluphenazine decanoate (depot) and enanthate for schizophrenia.
Topics: Administration, Oral; Antipsychotic Agents; Delayed-Action Preparations; Fluphenazine; Humans; Injections, Intramuscular; Randomized Controlled Trials as Topic; Schizophrenia | 2015 |
4 trial(s) available for fluphenazine enanthate and fluphenazine
Article | Year |
---|---|
Early unwanted effects of fluphenazine esters related to plasma fluphenazine concentrations in schizophrenic patients.
Topics: Adult; Female; Fluphenazine; Humans; Male; Middle Aged; Prolactin; Schizophrenia | 1985 |
Fluphenazine enanthate and fluphenazine decanoate in the treatment of schizophrenic outpatients: extrapyramidal symptoms and therapeutic effect.
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Basal Ganglia Diseases; Clinical Trials as Topic; Double-Blind Method; Female; Fluphenazine; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Random Allocation; Schizophrenia; Schizophrenic Psychology | 1982 |
Depot fluphenazine: risk/benefit ratio.
Topics: Administration, Oral; Basal Ganglia Diseases; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Female; Fluphenazine; Humans; Injections, Intramuscular; Male; Patient Compliance; Psychotic Disorders; Receptors, Dopamine; Research Design; Risk; Schizophrenia; Schizophrenic Psychology | 1984 |
The use of depot neuroleptics: clinical experience in the United States.
Topics: Administration, Oral; Adult; Clinical Trials as Topic; Depressive Disorder; Drug Administration Schedule; Female; Fluphenazine; Humans; Male; Patient Readmission; Placebos; Psychotic Disorders; Recurrence; Schizophrenia; Schizophrenic Psychology; United States | 1984 |
21 other study(ies) available for fluphenazine enanthate and fluphenazine
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
[Effect of a single dose of some long-acting neuroleptics on the estrus cycle and the mammary gland of the rat].
Topics: Animals; Antipsychotic Agents; Caproates; Estrus; Female; Flupenthixol; Fluphenazine; Mammary Glands, Animal; Organ Size; Ovary; Phenothiazines; Pregnancy; Pseudopregnancy; Rats; Thiazines; Uterus | 1979 |
Induction of tardive dyskinesia in Cebus apella and Macaca speciosa monkeys: a review.
Topics: Animals; Antipsychotic Agents; Benztropine; Cebus; Death, Sudden; Disease Models, Animal; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Fluphenazine; Haloperidol; Humans; Macaca; Male; Motor Activity; Stereotyped Behavior; Substance Withdrawal Syndrome | 1985 |
The Pisa syndrome during maintenance antipsychotic therapy.
Topics: Adult; Antipsychotic Agents; Dystonia; Female; Fluphenazine; Humans; Schizophrenia | 1986 |
More than mere shots.
Topics: Chronic Disease; Communication; Fluphenazine; Haloperidol; Humans; Mental Disorders; Patient Care Team; Psychiatric Aides; Psychiatric Nursing | 1988 |
Vitiligo-like syndrome following the use of fluphenazine enanthate.
Topics: Adult; Female; Fluphenazine; Humans; Schizophrenia; Vitiligo | 1985 |
Plasma levels of neuroleptic in patients receiving depot fluphenazine.
Topics: Delayed-Action Preparations; Fluphenazine; Humans; Regression Analysis; Schizophrenia | 1985 |
Pharmacotherapy and suicide risk in schizophrenia.
Topics: Adult; Antipsychotic Agents; Depressive Disorder; Drug Therapy, Combination; Female; Fluphenazine; Humans; Male; Risk; Schizophrenia; Suicide | 1983 |
Monkey models of tardive dyskinesia.
Topics: Animals; Benztropine; Biperiden; Cebus; Disease Models, Animal; Dyskinesia, Drug-Induced; Female; Fluphenazine; Macaca; Male; Parasympatholytics; Species Specificity; Syndrome | 1983 |
A monkey model of tardive dyskinesia (TD): evidence that reversible TD may turn into irreversible TD.
Topics: Animals; Cebus; Disease Models, Animal; Dyskinesia, Drug-Induced; Female; Fluphenazine; Humans; Stress, Psychological; Time Factors | 1982 |
Multiple congenital abnormalities in a newborn boy associated with maternal use of fluphenazine enanthate and other drugs during pregnancy.
Topics: Abnormalities, Drug-Induced; Cleft Lip; Cleft Palate; Dicyclomine; Doxylamine; Female; Fluphenazine; Humans; Hypertelorism; Infant, Newborn; Male; Perineum; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Pyridoxine; Schizophrenia, Disorganized | 1982 |
Catalepsy produced by long-acting neuroleptics, fluphenazine enanthate and fluphenazine decanoate, in mice.
Topics: Aminooxyacetic Acid; Animals; Antiparkinson Agents; Catalepsy; Delayed-Action Preparations; Drug Synergism; Enkephalins; Fluphenazine; Haloperidol; Humans; Male; Mice; Mice, Inbred Strains; Receptors, Dopamine | 1982 |
CLINICAL TRIAL OF FLUPHENAZINE ENANTHATE-- A LONG-ACTING INJECTABLE TRANQUILIZER.
Topics: Biomedical Research; Fluphenazine; Humans; Hypnotics and Sedatives; Schizophrenia | 1964 |
A CONTROLLED STUDY OF FLUPHENAZINE ENANTHATE IN CHRONIC SCHIZOPHRENIC PATIENTS.
Topics: Biomedical Research; Delayed-Action Preparations; Drug Therapy; Fluphenazine; Geriatrics; Humans; Injections; Injections, Subcutaneous; Research Design; Schizophrenia; Sesame Oil | 1965 |
THE DISTRIBUTION AND METABOLISM OF FLUPHENAZINE ENANTHATE.
Topics: Brain; Carbon Isotopes; Chromatography; Fluphenazine; Liver; Lung; Metabolism; Radiometry; Rats; Research | 1965 |
A DOUBLE BLIND STUDY OF FLUPHENAZINE ENANTHATE.
Topics: Delayed-Action Preparations; Double-Blind Method; Drug Therapy; Fluphenazine; Geriatrics; Humans; Injections; Injections, Subcutaneous; Schizophrenia; Toxicology | 1965 |
Diphenyl diselenide decreases the prevalence of vacuous chewing movements induced by fluphenazine in rats.
Topics: Animals; Antioxidants; Antipsychotic Agents; Behavior, Animal; Benzene Derivatives; Disease Models, Animal; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Fluphenazine; Male; Mastication; Organoselenium Compounds; Oxidative Stress; Rats; Rats, Wistar | 2007 |
Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilities.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Drug Utilization; Female; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Kaplan-Meier Estimate; Length of Stay; Male; Microspheres; Middle Aged; Patient Discharge; Proportional Hazards Models; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2010 |
Ten year outcomes of outpatients with schizophrenia on conventional depot antipsychotics: a systematic chart review.
Topics: Adult; Antipsychotic Agents; Delayed-Action Preparations; Drug Combinations; Female; Fluphenazine; Haloperidol; Humans; International Classification of Diseases; Longitudinal Studies; Maintenance Chemotherapy; Male; Medical Records; Medication Adherence; Middle Aged; Retrospective Studies; Schizophrenia; Secondary Prevention; Treatment Outcome | 2013 |
Effect of Hypericum perforatum on different models of movement disorders in rats.
Topics: Animals; Disease Models, Animal; Fluphenazine; Hypericum; Male; Mastication; Motor Activity; Movement Disorders; Plant Extracts; Rats; Rats, Wistar; Reserpine | 2013 |
Bioconversion and P-gp-Mediated Transport of Depot Fluphenazine Prodrugs after Intramuscular Injection.
Topics: Butyrylcholinesterase; Decanoates; Fluphenazine; Heptanoates; Humans; Injections, Intramuscular; Prodrugs | 2023 |